Study: Enlarged Prostate (Benign Prosatic Hyperplasia ) Bibliography



Also see discussion of enlarged prostate (benign prosatic hyperplasia) and research.

  1. Lees AM, Mok HYI, Lee RS, et al. Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis 1977;28:32538.
  2. Pelletier X, Belbraouet S, Mirabel D, et al. A diet moderately enriched in phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans. Ann Nutr Metab 1995;39:2915.
  3. Jones PJ, Raeini-Sarjaz M, Ntanios FY, et al. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 2000;41:697705.
  4. Grundy SM, Ahrens EH Jr, Davignon J. The interaction of cholesterol absorption and cholesterol synthesis in man. J Lipid Res 1969;10:30415 [review].
  5. Berges RR, Windeler J, Trampisch HJ, et al. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Lancet 1995;345:152932.
  6. Kiriakdis S, Stathi S, Jha HC, et al. Fatty acid esters of sitosterol 3-glucoside from soybeans and tempeh (fermented soybeans) as antiproliferative substances. J Clin Biochem Nutr 1997;22:13947.
  7. Awad AB, Chan KC, Downie AC, Fink CS. Peanuts as a source of -sitosterol, a sterol with anticancer properties. Nutr Cancer 2000;36:23841.
  8. Berges RR, Windeler J, Trampisch HJ, et al. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Lancet 1995;345:152932.
  9. Klippel KF, Hiltl DM, Schipp B. A multicentric, placebo-controlled, double-blind clinical trial of -sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. Br J Urol 1997;80:42732.